Comprehensive High-Resolution Anoscopy (HRA) Course

Is this educational activity right for me?

This online course provides a clear, comprehensive overview of High-Resolution Anoscopy (HRA), including equipment, technique, lesion recognition, and biopsy principles. Participants will learn how to approach the anal transformation zone systematically and interpret common benign, preinvasive, and suspicious findings. The session is designed for clinicians who want a structured overview of HRA before advancing to hands-on or case-based training.

Important information about the Comprehensive HRA Online Course

• This material is didactic; There is no hands-on component.
• This program provides a Certificate of Completion indicating the successful completion of the course. Independent certification is not provided.

Continuing Medical Education (CME)

Release Date:06/01/2026
Expiration Date:06/01/2029

Educational Objectives

Upon completion of this educational activity, participants should be able to:

• Understand the epidemiology of anal cancer.
• Discuss who and how to screen for anal cancer.
• Explain the anal anatomy and how to prepare for HRA.
• Demonstrate performing the screening methods and HRA.
• Teach HRA Terminology and demonstrate lesions within the anal canal.
• Apply the anal screening guidelines to cases.

ACCME Accreditation Statement
The ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Credit Designation Statement 
The ASCCP designates this live activity for a maximum of 5  AMA PRA Category 1 Credits ™ .  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure Information 

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ASCCP any financial relationship(s) that have occurred within the prior 24 months with any ineligible companies. Financial relationships are defined as remuneration in any amount from ineligible companies in the form of grants, research support, consulting fees, salary, ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds), honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors, or other financial benefits. The intent of this disclosure is not to prevent individuals with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ASCCP has reviewed all disclosures and mitigated all relevant financial relationships that have been identified.

The following person(s) disclosed financial relationships:

• Mark Einstein, MD, MS – Antiva (Consultant), Merck (Consultant), Papivax (Consultant), PDS Biotechnologies (Consultant), LinKinVax (Consultant), Aserls Pharmaceuticals (Consultant) – Faculty
• Lisa Flowers, MD, MPH – PI on Luviva trial sponsored by Guided Therapeutics (Grant Recipient) – Faculty

The following person(s) disclosed no financial relationships:

• Patricia Jeudin, MD – Faculty
• Yuxin Liu, MD, PhD – Faculty
• Cassidy Brown – Staff
• Diane Catalano – Staff
• Kerry Curtis – Staff
• Eric Grammer – Staff
• Connor Hendrix – Staff
• Jenn Natale – Staff
• Robert Pulley – Staff
• Joseph Pymm – Staff
• Nicole Ratner – Staff
• Liesl Robinson – Staff

Faculty

Mark H. Einstein, MD, MSDr. Einstein is Professor and Chair of Obstetrics & Gynecology and Women’s Health at Montefiore Medical Center and the Albert Einstein College of Medicine. He has served in numerous leadership roles for many national and international OB/GYN and cancer-focused groups, including the World Health Organization, the US National Cancer Institute, ASCCP, the American Cancer Society, and the Society of Gynecologic Oncologists. He is a Past President of the ASCCP, the Society of Lower Genital Tract Diseases. He has served in public policy roles in the US and globally as a leader in clinical guidelines development for cervical cancer screening. He has also served in roles for the CDC and Departments of Health in guiding cancer prevention and control strategies, particularly in vulnerable and marginalized populations.

Lisa Flowers, M.D., MPH, FACOGDr. Lisa Flowers is a Professor in the Department of Obstetrics and Gynecology who has dedicated her career to improving health outcomes in HIV populations. She is the Director of Colposcopy and Anoscopy clinics at Georgia Cancer Center of Excellence and the Ponce de Leon Center. She is a gynecologist engaged in health disparities in HIV populations and a translational researcher in screening, detection, and treatment of HPV related diseases. Dr. Flowers is the Emory Principal Investigator (PI) for the AIDS Malignancy Consortium testing novel treatments to stop the development of virally mediated cancers and site PI for the NIH/NCI multi-site study Anal Cancer/HSIL Outcomes Research Study focusing on HPV related precancerous cells in people with HIV. In addition, she is the PI for the NCI CASCADE study in Georgia, one of only two sites in the US to identify cervical cancer screening strategies using self-collection in women with HIV.

Patricia P. Jeudin MDDr. Jeudin is a gynecologist at the Sylvester Comprehensive Cancer Center in the division of gynecological oncology. Her clinical and research focus is on women with lower genitourinary tract disease from chronic HPV infection. She has an interest in outcomes based on race and ethnicity and how to mitigate disparities in cancer outcomes.

Yuxin Liu, MD, PhDDr. Yuxin Liu is a Professor of Pathology and Director of the Gynecologic Pathology Service and Fellowship Program. Her academic focus centers on HPV-associated cervical and anal cancers, with a strong commitment to advancing translational research in these areas.

Pricing

Not an ASCCP Member?  Join now  to get discounted registration.

Registration Type	Price
ASCCP Physician Member	$350.00
Physician Non-Member	$650.00
ASCCP Physician Assistant, Nurse/Nurse Practitioner/Midwife, Researcher Member	$275.00
Physician Assistant, Nurse/Nurse Practitioner/Midwife, Researcher Non-Member	$475.00
ASCCP Trainee	$125.00
Trainee Non-Member	$225.00

Registration is non-transferable.

Program

1. The ABC’s of Anal Cancer Screening
2. Epidemiology of Anal Cancer
3. HPV Vaccines
4. Who to Screen for Anal Cancer
5. Anal Anatomy and How to Screen for Anal Cancer
6. High Resolution Anoscopy (HRA) Terminology
7. High Resolution Anoscopy/ The Basics
8. High Resolution Anoscopy
9. Management of Results and Treatments
10. Patient-Applied Treatment for Anal SIL
11. Anal Pathology
12. HRA Course Atlas
13. HRA Cases